Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease

Laboratory Investigation

Volumn 89, Issue 6, 2009, Pages 624-635

  Choi, Ed M ^a,c   Geschwind, Michael D ^a,b   Deering, Camille ^a   Pomeroy, Kristen ^a   Kuo, Amy ^a   Miller, Bruce L ^a,b   Safar, Jiri G ^a,b,d   Prusiner, Stanley B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Assay; Blood; CreutzfeldtJakob disease; Detection; Prion; WBC

Indexed keywords

CD4 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; L SELECTIN; PRION PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CELL FRACTIONATION; CELL SUBPOPULATION; CELL SURFACE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOCYTE; HELPER CELL; HUMAN; LEUKOCYTE; MALE; MEMORY CELL; MOLECULE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; THROMBOCYTE;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PROTEIN ISOFORMS; PRPC PROTEINS; PRPSC PROTEINS;

EID: 66549125845     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.30     Document Type: Article

References (52)

1. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-188.
2. Will RG, Alpers MP, Dormont D, et al. Infectious and sporadic prion diseases. In: Prusiner SB (ed). Prion Biology and Diseases, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 2004, pp 629-671.
3. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982;218:1309-1311.
4. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-144.
5. Hsiao K, Baker HF, Crow TJ, et al. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 1989;338: 342-345.
6. Owen F, Poulter M, Lofthouse R, et al. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1989;333:51-52.
7. Pan K-M, Baldwin M, Nguyen J, et al. Conversion of a-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993;90:10962-10966.
8. Borchelt DR, Scott M, Taraboulos A, et al. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990;110:743-752.
9. Ramasamy I, Law M, Collins S, et al. Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease. Lancet Infect Dis 2003;3:214-222.
10. Glatzel M, Abela E, Maissen M, et al. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;349:1812-1820.
11. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358: 171-180.
12. Cashman NR, Loertscher R, Nalbantoglu J, et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990;61:185-192.
13. Fraser H, Brown KL, Stewart K, et al. Replication of scrapie in spleens of SCID mice follows reconstitution with wild-type mouse bone marrow. J Gen Virol 1996;77:1935-1940.
14. Blattler T, Brandner S, Raeber AJ, et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 1997;389:69-73.
15. Brown KL, Stewart K, Ritchie DL, et al. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med 1999;5:1308-1312.
16. Brown P. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy. Vox Sang 2005;89: 63-70.
17. Brown P, Cervenáková L, McShane LM, et al. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999;39:1169-1178.
18. Cervenáková L, Yakovleva O, McKenzie C, et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003;43:1687-1694.
19. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-421.
20. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-529.
21. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368:2061-2067.
22. Health Protection Agency. Variant CJD and plasma products. http:// www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb-C/ 1195733818681?p = 1225960597236, 2009.
23. Castilla J, Saa P, Soto C. Detection of prions in blood. Nat Med 2005;11:982-985.
24. Safar JG, Wille H, Geschwind MD, et al. Human prions and plasma lipoproteins. Proc Natl Acad Sci USA 2006;103:11312-11317.
25. sc molecules with different conformations. Nat Med 1998;4:1157-1165.
26. Safar JG, Scott M, Monaghan J, et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 2002;20: 1147-1150.
27. Safar JG, Geschwind MD, Deering C, et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005;102:3501-3506.
28. Oberyszyn AS. Method for visualizing aerosol contamination in flow sorters. Curr Protoc Cytom 2002;19:3.5.1-3.5.7.
29. Leclerc E, Peretz D, Ball H, et al. Conformation of PrPC on the cell surface as probed by antibodies. J Mol Biol 2003;326:475-483.
30. Bellon A, Seyfert-Brandt W, Lang W, et al. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol 2003;84:1921-1925.
31. Kascsak RJ, Rubenstein R, Merz PA, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987;61:3688-3693.
32. Mehlhorn I, Groth D, Stöckel J, et al. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 1996;35:5528-5537.
33. Büeler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993;73:1339-1347.
34. Prusiner SB, Groth D, Serban A, et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 1993;90:10608-10612.
35. Barclay GR, Hope J, Birkett CR, et al. Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry. Br J Haematol 1999;107:804-814.
36. Mouillet-Richard S, Ermonval M, Chebassier C, et al. Signal transduction through prion protein. Science 2000;289:1925-1928.
37. Schmitt-Ulms G, Legname G, Baldwin MA, et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001;314:1209-1225.
38. Schneider B, Mutel V, Pietri M, et al. NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 2003;100: 13326-13331.
39. fyn and to enhance neurite outgrowth. J Cell Biol 2005;169:341-354.
40. Pan K-M, Stahl N, Prusiner SB. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci 1992;1: 1343-1352.
41. 27-30 is a normal soluble prion protein fragment released by human platelets. Biochem Biophys Res Commun 1996;223:572-577.
42. C) expression on hamster, mouse and human blood cells. Br J Haematol 2000;110:472-480.
43. Evans EJ, Hene L, Sparks LM, et al. The T cell surface - how well do we know it? Immunity 2003;19:213-223.
44. Viegas P, Chaverot N, Enslen H, et al. Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J Cell Sci 2006;119: 4634-4643.
45. Fagge T, Barclay GR, Macgregor I, et al. Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry. Transfusion 2005;45:504-513.
46. Volkel D, Zimmermann K, Zerr I, et al. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 2001;41:441-448.
47. Zou S, Fang CT, Schonberger LB. Transfusion transmission of human prion diseases. Transfus Med Rev 2008;22:58-69.
48. Gregori L, Gurgel PV, Lathrop JT, et al. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 2006;368: 2226-2230.
49. Hunter N, Foster J, Chong A, et al. Transmission of prion disease by blood transfusion. J Gen Virol 2002;83:2897-2905.
50. Mathiason CK, Powers JG, Dahmes SJ, et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 2006;314:133-136.
51. Houston F, McCutcheon S, Goldmann W, et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008;112:4739-4745.
52. Korth C, Kaneko K, Groth D, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse - human prion protein transgene. Proc Natl Acad Sci USA 2003;100: 4784-4789.